UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What to Know About the Alzheimer Drug Aducanumab (Aduhelm)

JAMA internal medicine, 2022-08, Vol.182 (8), p.892

2022

Volltextzugriff (PDF)

Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records

Annals of internal medicine, 2011-08, Vol.155 (3), p.137

2011

Volltextzugriff (PDF)

Distribution of C-Reactive Protein Values in the United States

The New England journal of medicine, 2005-04, Vol.352 (15), p.1611-1613

2005

Volltextzugriff (PDF)

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials

Annals of internal medicine, 2016-09, Vol.165 (6), p.421

2016

Volltextzugriff (PDF)

Skin biopsy rates and incidence of melanoma: population based ecological study

BMJ, 2005-09, Vol.331 (7515), p.481

International edition, 2005

Volltextzugriff (PDF)

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation

JAMA : the journal of the American Medical Association, 2016-04, Vol.315 (14), p.1516

2016

Volltextzugriff (PDF)

False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications

The New England journal of medicine, 2020-08, Vol.383 (6), p.e38-e38

2020

Volltextzugriff (PDF)

Overdiagnosis: it’s official

BMJ (Online), 2021-11, p.n2854

2021

Volltextzugriff (PDF)

Disclosure of study funding and author conflicts of interest in press releases and the news: a retrospective content analysis with two cohorts

BMJ open, 2021-01, Vol.11 (1), p.e041385-e041385

2021

Volltextzugriff (PDF)

Giving legs to restless legs: a case study of how the media helps make people sick

PLoS medicine, 2006-04, Vol.3 (4), p.e170

2006

Volltextzugriff (PDF)

Medical Marketing in the United States, 1997-2016

JAMA : the journal of the American Medical Association, 2019-01, Vol.321 (1), p.80

2019

Volltextzugriff (PDF)

Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial

JAMA internal medicine, 2022-03, Vol.182 (3), p.332

2022

Volltextzugriff (PDF)

Media reporting on research presented at scientific meetings: more caution needed

Medical journal of Australia, 2006-06, Vol.184 (11), p.576-580

2006

Volltextzugriff (PDF)

Direct-to-Consumer Low-Testosterone Clinics-Where Is the Federation of State Medical Boards?

JAMA internal medicine, 2023-04, Vol.183 (4), p.288

2023

Volltextzugriff (PDF)

Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States

Annals of internal medicine, 2012-03, Vol.156 (5), p.340

2012

Volltextzugriff (PDF)

The Fate of FDA Postapproval Studies

The New England journal of medicine, 2017-09, Vol.377 (12), p.1114-1117

2017

Volltextzugriff (PDF)

Website Content and Funding of Officially Recognized Disease Awareness Campaigns

JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (7), p.589

2024

Volltextzugriff (PDF)

Communicating data about the benefits and harms of treatment: a randomized trial

Annals of internal medicine, 2011-07, Vol.155 (2), p.87

2011

Volltextzugriff (PDF)

A Clear-eyed View of Restasis and Chronic Dry Eye Disease

JAMA internal medicine, 2018-02, Vol.178 (2), p.181

2018

Volltextzugriff (PDF)

US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up

JAMA internal medicine, 2016-04, Vol.176 (4), p.439

2016

Volltextzugriff (PDF)

Policy makers must act on incomplete evidence in responding to COVID-19

Cochrane database of systematic reviews, 2020-11, Vol.11 (11), p.ED000149-ED000149

2020

Volltextzugriff (PDF)

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs

JAMA internal medicine, 2021-11, Vol.181 (11), p.1521

2021

Volltextzugriff (PDF)

Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review

BMJ, 2010-08, Vol.341 (7769), p.c3920-c3920

International edition, 2010

Volltextzugriff (PDF)

Using a drug facts box to communicate drug benefits and harms: two randomized trials

Annals of internal medicine, 2009-04, Vol.150 (8), p.516

2009

Volltextzugriff (PDF)

The New USPSTF Mammography Recommendations — A Dissenting View

The New England journal of medicine, 2023-09, Vol.389 (12), p.1061-1064

2023

Volltextzugriff (PDF)

1 – 25 von 126

Suche als RSS-Feed

Aktive Filter

ThemaMedicine, General & Internal

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(114)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(126)

Sprache

Englisch
(126)

Erscheinungsjahr

n.n

Thema

General & Internal Medicine
(126)
Life Sciences & Biomedicine
(126)
Science & Technology
(126)
Humans
(100)
Female
(49)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
United States
(36)
Male
(35)
Middle Aged
(30)
Aged
(26)
Adult
(24)
General Aspects
(24)
Public Health. Hygiene
(16)
Public Health. Hygiene-Occupational Medicine
(16)
Breast Cancer
(15)
United States Food And Drug Administration
(15)
Mortality
(13)
Physicians
(13)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

What to Know About the Alzheimer Drug Aducanumab (Aduhelm)

Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records

Distribution of C-Reactive Protein Values in the United States

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials

Skin biopsy rates and incidence of melanoma: population based ecological study

Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation

False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications

Overdiagnosis: it’s official

Disclosure of study funding and author conflicts of interest in press releases and the news: a retrospective content analysis with two cohorts

Giving legs to restless legs: a case study of how the media helps make people sick

Medical Marketing in the United States, 1997-2016

Assessing How Consumers Interpret and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial

Media reporting on research presented at scientific meetings: more caution needed

Direct-to-Consumer Low-Testosterone Clinics-Where Is the Federation of State Medical Boards?

Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States

The Fate of FDA Postapproval Studies

Website Content and Funding of Officially Recognized Disease Awareness Campaigns

Communicating data about the benefits and harms of treatment: a randomized trial

A Clear-eyed View of Restasis and Chronic Dry Eye Disease

US Food and Drug Administration Approval of Flibanserin: Even the Score Does Not Add Up

Policy makers must act on incomplete evidence in responding to COVID-19

Communication of Survival Data in US Food and Drug Administration-Approved Labeling of Cancer Drugs

Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review

Using a drug facts box to communicate drug benefits and harms: two randomized trials

The New USPSTF Mammography Recommendations — A Dissenting View

Aktive Filter

Suchergebnisse filtern